pyrazolo(1-5-a)pyrimidine has been researched along with HIV-Infections* in 1 studies
1 other study(ies) available for pyrazolo(1-5-a)pyrimidine and HIV-Infections
Article | Year |
---|---|
Pyrazolo[1,5-a]pyrimidine-based macrocycles as novel HIV-1 inhibitors: a patent evaluation of WO2015123182.
The emergence of drug resistance in Combination Antiretroviral Therapy (cART) confirms a continuing need to investigate novel HIV-1 inhibitors with unexplored mechanisms of action. Recently, a series of pyrazolopyrimidine-based macrocyclic compounds were reported as inhibitors of HIV-1 replication disclosed in the patent WO2015123182. Most of the disclosed compounds possessed in vitro antiviral potency in single-digit nanomolar range, which were determined by MT-2 cell assay. Then, the structural diversity, pharmacophore similarity of HIV-1 IN-LEDGF/p75 inhibitors, and implications for drug design were analyzed. In the end of this article, a glimpse of some macrocycles as potent antiviral agents (drug candidates) was provided. Some strategies and technologies enabling macrocycle design were also described. We expect that further development of these macrocyclic compounds will offer new anti-HIV-1 drug candidates. Topics: Anti-HIV Agents; Drug Design; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Patents as Topic; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2016 |